Timapiprant

DB11900InvestigationalSmall molecule

OC000459 is under investigation for the treatment of Severe Eosinophilic Asthma. OC000459 has been investigated for the treatment of Bronchial Asthma.

Mechanism: Pharmacologically active on Prostaglandin D2 receptor 2
Curator reviewed
Formula / weight: C₂₁H₁₇FN₂O₂ · 348.377 g/mol (avg)
Code names: OC-000459 · OC-459

Resolves to

Compound

UNII04XB9TB8OLCAS851723-84-7ChEMBLCHEMBL560993PubChem11462174

Structure

InChIKeyFATGTHLOZSXOBC-UHFFFAOYSA-NSMILESCC1=C(CC2=CC=C3C=CC=CC3=N2)C2=CC(F)=CC=C2N1CC(O)=O

Targets

Q9Y5Y4PTGDR2

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

9Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Timapiprant, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account